APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oncology Injection Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Oncology Injection Drug Market Analysis and Forecast 2026-2032

26 December 2025190 pages

Choose your research edition.

Industry ResearchOncology Injection Drug Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Oncology Injection Drug Industry Growth and Trends Forecast to 2032115 pages · $3,450 USDMarket StructureGlobal Oncology Injection Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oncology Injection Drug Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Oncology Injection Drug Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Oncology Injection Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Oncology Injection Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Oncology Injection Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Oncology Injection Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Oncology Injection Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Oncology Injection Drug include AdvaCare, Allos Therapeutics, Alza, Celgene, CordenPharma, Debiopharm, Ferring Pharmaceuticals, Genzyme and Merrimack, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Oncology Injection Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Oncology Injection Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Oncology Injection Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Oncology Injection Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Oncology Injection Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Oncology Injection Drug sales, projected growth trends, production technology, application and end-user industry.

Oncology Injection Drug Segment by Company

AdvaCare

Allos Therapeutics

Alza

Celgene

CordenPharma

Debiopharm

Ferring Pharmaceuticals

Genzyme

Merrimack

Millennium Pharmaceuticals

Pharmascience

Praecis Pharmaceuticals

S.G. Biopharm

Taj Oncology

Eli Lilly

Oncology Injection Drug Segment by Type

Central Nervous System

Circulatory/Musculoskeletal System

Organs

Other

Oncology Injection Drug Segment by Application

Myeloma

Lymphoma

Prostate Cancer

Other

Oncology Injection Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oncology Injection Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oncology Injection Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oncology Injection Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Oncology Injection Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Oncology Injection Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oncology Injection Drug sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Oncology Injection Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Central Nervous System Major Manufacturers Table 3. Circulatory/Musculoskeletal System Major Manufacturers Table 4. Organs Major Manufacturers Table 5. Other Major Manufacturers Table 6. Global Oncology Injection Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Myeloma Major Manufacturers Table 8. Lymphoma Major Manufacturers Table 9. Prostate Cancer Major Manufacturers Table 10. Other Major Manufacturers Table 11. Oncology Injection Drug Industry Trends Table 12. Oncology Injection Drug Industry Drivers Table 13. Oncology Injection Drug Industry Opportunities and Challenges Table 14. Oncology Injection Drug Industry Restraints Table 15. Global Oncology Injection Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Oncology Injection Drug Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Oncology Injection Drug Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Oncology Injection Drug Revenue Market Share by Region (2021-2026) Table 19. Global Oncology Injection Drug Revenue Market Share by Region (2027-2032) Table 20. Global Oncology Injection Drug Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 21. Global Oncology Injection Drug Sales by Region (2021-2026) & (K Units) Table 22. Global Oncology Injection Drug Sales by Region (2027-2032) & (K Units) Table 23. Global Oncology Injection Drug Sales Market Share by Region (2021-2026) Table 24. Global Oncology Injection Drug Sales Market Share by Region (2027-2032) Table 25. Global Oncology Injection Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Oncology Injection Drug Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Oncology Injection Drug Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Oncology Injection Drug Sales Market Share by Manufacturers (2021-2026) Table 29. Global Oncology Injection Drug Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 30. Global Oncology Injection Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Oncology Injection Drug Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Oncology Injection Drug Manufacturers, Product Type & Application Table 33. Global Oncology Injection Drug Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Oncology Injection Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Oncology Injection Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Oncology Injection Drug Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Oncology Injection Drug Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Oncology Injection Drug Revenue Market Share by Type (2021-2026) Table 40. Global Oncology Injection Drug Revenue Market Share by Type (2027-2032) Table 41. Global Oncology Injection Drug Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 42. Global Oncology Injection Drug Sales by Type (2021-2026) & (K Units) Table 43. Global Oncology Injection Drug Sales by Type (2027-2032) & (K Units) Table 44. Global Oncology Injection Drug Sales Market Share by Type (2021-2026) Table 45. Global Oncology Injection Drug Sales Market Share by Type (2027-2032) Table 46. Global Oncology Injection Drug Price by Type (2021-2026) & (US$/Unit) Table 47. Global Oncology Injection Drug Price by Type (2027-2032) & (US$/Unit) Table 48. Global Oncology Injection Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Oncology Injection Drug Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Oncology Injection Drug Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Oncology Injection Drug Revenue Market Share by Application (2021-2026) Table 52. Global Oncology Injection Drug Revenue Market Share by Application (2027-2032) Table 53. Global Oncology Injection Drug Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 54. Global Oncology Injection Drug Sales by Application (2021-2026) & (K Units) Table 55. Global Oncology Injection Drug Sales by Application (2027-2032) & (K Units) Table 56. Global Oncology Injection Drug Sales Market Share by Application (2021-2026) Table 57. Global Oncology Injection Drug Sales Market Share by Application (2027-2032) Table 58. Global Oncology Injection Drug Price by Application (2021-2026) & (US$/Unit) Table 59. Global Oncology Injection Drug Price by Application (2027-2032) & (US$/Unit) Table 60. AdvaCare Company Information Table 61. AdvaCare Business Overview Table 62. AdvaCare Oncology Injection Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 63. AdvaCare Oncology Injection Drug Product Portfolio Table 64. AdvaCare Recent Development Table 65. Allos Therapeutics Company Information Table 66. Allos Therapeutics Business Overview Table 67. Allos Therapeutics Oncology Injection Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Allos Therapeutics Oncology Injection Drug Product Portfolio Table 69. Allos Therapeutics Recent Development Table 70. Alza Company Information Table 71. Alza Business Overview Table 72. Alza Oncology Injection Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Alza Oncology Injection Drug Product Portfolio Table 74. Alza Recent Development Table 75. Celgene Company Information Table 76. Celgene Business Overview Table 77. Celgene Oncology Injection Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Celgene Oncology Injection Drug Product Portfolio Table 79. Celgene Recent Development Table 80. CordenPharma Company Information Table 81. CordenPharma Business Overview Table 82. CordenPharma Oncology Injection Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. CordenPharma Oncology Injection Drug Product Portfolio Table 84. CordenPharma Recent Development Table 85. Debiopharm Company Information Table 86. Debiopharm Business Overview Table 87. Debiopharm Oncology Injection Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Debiopharm Oncology Injection Drug Product Portfolio Table 89. Debiopharm Recent Development Table 90. Ferring Pharmaceuticals Company Information Table 91. Ferring Pharmaceuticals Business Overview Table 92. Ferring Pharmaceuticals Oncology Injection Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Ferring Pharmaceuticals Oncology Injection Drug Product Portfolio Table 94. Ferring Pharmaceuticals Recent Development Table 95. Genzyme Company Information Table 96. Genzyme Business Overview Table 97. Genzyme Oncology Injection Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Genzyme Oncology Injection Drug Product Portfolio Table 99. Genzyme Recent Development Table 100. Merrimack Company Information Table 101. Merrimack Business Overview Table 102. Merrimack Oncology Injection Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Merrimack Oncology Injection Drug Product Portfolio Table 104. Merrimack Recent Development Table 105. Millennium Pharmaceuticals Company Information Table 106. Millennium Pharmaceuticals Business Overview Table 107. Millennium Pharmaceuticals Oncology Injection Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Millennium Pharmaceuticals Oncology Injection Drug Product Portfolio Table 109. Millennium Pharmaceuticals Recent Development Table 110. Pharmascience Company Information Table 111. Pharmascience Business Overview Table 112. Pharmascience Oncology Injection Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Pharmascience Oncology Injection Drug Product Portfolio Table 114. Pharmascience Recent Development Table 115. Praecis Pharmaceuticals Company Information Table 116. Praecis Pharmaceuticals Business Overview Table 117. Praecis Pharmaceuticals Oncology Injection Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Praecis Pharmaceuticals Oncology Injection Drug Product Portfolio Table 119. Praecis Pharmaceuticals Recent Development Table 120. S.G. Biopharm Company Information Table 121. S.G. Biopharm Business Overview Table 122. S.G. Biopharm Oncology Injection Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. S.G. Biopharm Oncology Injection Drug Product Portfolio Table 124. S.G. Biopharm Recent Development Table 125. Taj Oncology Company Information Table 126. Taj Oncology Business Overview Table 127. Taj Oncology Oncology Injection Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. Taj Oncology Oncology Injection Drug Product Portfolio Table 129. Taj Oncology Recent Development Table 130. Eli Lilly Company Information Table 131. Eli Lilly Business Overview Table 132. Eli Lilly Oncology Injection Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 133. Eli Lilly Oncology Injection Drug Product Portfolio Table 134. Eli Lilly Recent Development Table 135. North America Oncology Injection Drug Revenue by Type (2021-2026) & (US$ Million) Table 136. North America Oncology Injection Drug Revenue by Type (2027-2032) & (US$ Million) Table 137. North America Oncology Injection Drug Sales by Type (2021-2026) & (K Units) Table 138. North America Oncology Injection Drug Sales by Type (2027-2032) & (K Units) Table 139. North America Oncology Injection Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 140. North America Oncology Injection Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 141. North America Oncology Injection Drug Revenue by Application (2021-2026) & (US$ Million) Table 142. North America Oncology Injection Drug Revenue by Application (2027-2032) & (US$ Million) Table 143. North America Oncology Injection Drug Sales by Application (2021-2026) & (K Units) Table 144. North America Oncology Injection Drug Sales by Application (2027-2032) & (K Units) Table 145. North America Oncology Injection Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 146. North America Oncology Injection Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 147. North America Oncology Injection Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 148. North America Oncology Injection Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 149. North America Oncology Injection Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 150. North America Oncology Injection Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 151. North America Oncology Injection Drug Sales by Country (2021-2026) & (K Units) Table 152. North America Oncology Injection Drug Sales by Country (2027-2032) & (K Units) Table 153. North America Oncology Injection Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 154. North America Oncology Injection Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 155. United States Oncology Injection Drug Revenue (2021-2032) & (US$ Million) Table 156. Canada Oncology Injection Drug Revenue (2021-2032) & (US$ Million) Table 157. Mexico Oncology Injection Drug Revenue (2021-2032) & (US$ Million) Table 158. Europe Oncology Injection Drug Revenue by Type (2021-2026) & (US$ Million) Table 159. Europe Oncology Injection Drug Revenue by Type (2027-2032) & (US$ Million) Table 160. Europe Oncology Injection Drug Sales by Type (2021-2026) & (K Units) Table 161. Europe Oncology Injection Drug Sales by Type (2027-2032) & (K Units) Table 162. Europe Oncology Injection Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 163. Europe Oncology Injection Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 164. Europe Oncology Injection Drug Revenue by Application (2021-2026) & (US$ Million) Table 165. Europe Oncology Injection Drug Revenue by Application (2027-2032) & (US$ Million) Table 166. Europe Oncology Injection Drug Sales by Application (2021-2026) & (K Units) Table 167. Europe Oncology Injection Drug Sales by Application (2027-2032) & (K Units) Table 168. Europe Oncology Injection Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 169. Europe Oncology Injection Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 170. Europe Oncology Injection Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 171. Europe Oncology Injection Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 172. Europe Oncology Injection Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 173. Europe Oncology Injection Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 174. Europe Oncology Injection Drug Sales by Country (2021-2026) & (K Units) Table 175. Europe Oncology Injection Drug Sales by Country (2027-2032) & (K Units) Table 176. Europe Oncology Injection Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 177. Europe Oncology Injection Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 178. Germany Oncology Injection Drug Revenue (2021-2032) & (US$ Million) Table 179. France Oncology Injection Drug Revenue (2021-2032) & (US$ Million) Table 180. U.K. Oncology Injection Drug Revenue (2021-2032) & (US$ Million) Table 181. Italy Oncology Injection Drug Revenue (2021-2032) & (US$ Million) Table 182. Russia Oncology Injection Drug Revenue (2021-2032) & (US$ Million) Table 183. Spain Oncology Injection Drug Revenue (2021-2032) & (US$ Million) Table 184. Netherlands Oncology Injection Drug Revenue (2021-2032) & (US$ Million) Table 185. Switzerland Oncology Injection Drug Revenue (2021-2032) & (US$ Million) Table 186. Sweden Oncology Injection Drug Revenue (2021-2032) & (US$ Million) Table 187. Poland Oncology Injection Drug Revenue (2021-2032) & (US$ Million) Table 188. China Oncology Injection Drug Revenue by Type (2021-2026) & (US$ Million) Table 189. China Oncology Injection Drug Revenue by Type (2027-2032) & (US$ Million) Table 190. China Oncology Injection Drug Sales by Type (2021-2026) & (K Units) Table 191. China Oncology Injection Drug Sales by Type (2027-2032) & (K Units) Table 192. China Oncology Injection Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 193. China Oncology Injection Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 194. China Oncology Injection Drug Revenue by Application (2021-2026) & (US$ Million) Table 195. China Oncology Injection Drug Revenue by Application (2027-2032) & (US$ Million) Table 196. China Oncology Injection Drug Sales by Application (2021-2026) & (K Units) Table 197. China Oncology Injection Drug Sales by Application (2027-2032) & (K Units) Table 198. China Oncology Injection Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 199. China Oncology Injection Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 200. Asia Oncology Injection Drug Revenue by Type (2021-2026) & (US$ Million) Table 201. Asia Oncology Injection Drug Revenue by Type (2027-2032) & (US$ Million) Table 202. Asia Oncology Injection Drug Sales by Type (2021-2026) & (K Units) Table 203. Asia Oncology Injection Drug Sales by Type (2027-2032) & (K Units) Table 204. Asia Oncology Injection Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 205. Asia Oncology Injection Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 206. Asia Oncology Injection Drug Revenue by Application (2021-2026) & (US$ Million) Table 207. Asia Oncology Injection Drug Revenue by Application (2027-2032) & (US$ Million) Table 208. Asia Oncology Injection Drug Sales by Application (2021-2026) & (K Units) Table 209. Asia Oncology Injection Drug Sales by Application (2027-2032) & (K Units) Table 210. Asia Oncology Injection Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 211. Asia Oncology Injection Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 212. Asia Oncology Injection Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 213. Asia Oncology Injection Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 214. Asia Oncology Injection Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 215. Asia Oncology Injection Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 216. Asia Oncology Injection Drug Sales by Country (2021-2026) & (K Units) Table 217. Asia Oncology Injection Drug Sales by Country (2027-2032) & (K Units) Table 218. Asia Oncology Injection Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 219. Asia Oncology Injection Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 220. Japan Oncology Injection Drug Revenue (2021-2032) & (US$ Million) Table 221. South Korea Oncology Injection Drug Revenue (2021-2032) & (US$ Million) Table 222. India Oncology Injection Drug Revenue (2021-2032) & (US$ Million) Table 223. Australia Oncology Injection Drug Revenue (2021-2032) & (US$ Million) Table 224. Taiwan Oncology Injection Drug Revenue (2021-2032) & (US$ Million) Table 225. Southeast Asia Oncology Injection Drug Revenue (2021-2032) & (US$ Million) Table 226. SAMEA Oncology Injection Drug Revenue by Type (2021-2026) & (US$ Million) Table 227. SAMEA Oncology Injection Drug Revenue by Type (2027-2032) & (US$ Million) Table 228. SAMEA Oncology Injection Drug Sales by Type (2021-2026) & (K Units) Table 229. SAMEA Oncology Injection Drug Sales by Type (2027-2032) & (K Units) Table 230. SAMEA Oncology Injection Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 231. SAMEA Oncology Injection Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 232. SAMEA Oncology Injection Drug Revenue by Application (2021-2026) & (US$ Million) Table 233. SAMEA Oncology Injection Drug Revenue by Application (2027-2032) & (US$ Million) Table 234. SAMEA Oncology Injection Drug Sales by Application (2021-2026) & (K Units) Table 235. SAMEA Oncology Injection Drug Sales by Application (2027-2032) & (K Units) Table 236. SAMEA Oncology Injection Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 237. SAMEA Oncology Injection Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 238. SAMEA Oncology Injection Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 239. SAMEA Oncology Injection Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 240. SAMEA Oncology Injection Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 241. SAMEA Oncology Injection Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 242. SAMEA Oncology Injection Drug Sales by Country (2021-2026) & (K Units) Table 243. SAMEA Oncology Injection Drug Sales by Country (2027-2032) & (K Units) Table 244. SAMEA Oncology Injection Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 245. SAMEA Oncology Injection Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 246. Brazil Oncology Injection Drug Revenue (2021-2032) & (US$ Million) Table 247. Argentina Oncology Injection Drug Revenue (2021-2032) & (US$ Million) Table 248. Chile Oncology Injection Drug Revenue (2021-2032) & (US$ Million) Table 249. Colombia Oncology Injection Drug Revenue (2021-2032) & (US$ Million) Table 250. Peru Oncology Injection Drug Revenue (2021-2032) & (US$ Million) Table 251. Saudi Arabia Oncology Injection Drug Revenue (2021-2032) & (US$ Million) Table 252. Israel Oncology Injection Drug Revenue (2021-2032) & (US$ Million) Table 253. UAE Oncology Injection Drug Revenue (2021-2032) & (US$ Million) Table 254. Turkey Oncology Injection Drug Revenue (2021-2032) & (US$ Million) Table 255. Iran Oncology Injection Drug Revenue (2021-2032) & (US$ Million) Table 256. Egypt Oncology Injection Drug Revenue (2021-2032) & (US$ Million) Table 257. Key Raw Materials Table 258. Raw Materials Key Suppliers Table 259. Oncology Injection Drug Distributors List Table 260. Oncology Injection Drug Customers List Table 261. Research Programs/Design for This Report Table 262. Authors List of This Report Table 263. Secondary Sources Table 264. Primary Sources List of Figures Figure 1. Oncology Injection Drug Image Figure 2. Global Oncology Injection Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oncology Injection Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Central Nervous System Image Figure 5. Circulatory/Musculoskeletal System Image Figure 6. Organs Image Figure 7. Other Image Figure 8. Global Oncology Injection Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Oncology Injection Drug Market Size Share 2021 VS 2025 VS 2032 Figure 10. Myeloma Image Figure 11. Lymphoma Image Figure 12. Prostate Cancer Image Figure 13. Other Image Figure 14. Global Oncology Injection Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Oncology Injection Drug Revenue (2021-2032) & (US$ Million) Figure 16. Global Oncology Injection Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Oncology Injection Drug Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Oncology Injection Drug Revenue Market Share by Region (2021-2032) Figure 19. Global Oncology Injection Drug Sales (2021-2032) & (K Units) Figure 20. Global Oncology Injection Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 21. Global Oncology Injection Drug Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Oncology Injection Drug Sales YoY (2021-2032) & (K Units) Figure 23. Europe Oncology Injection Drug Sales YoY (2021-2032) & (K Units) Figure 24. China Oncology Injection Drug Sales YoY (2021-2032) & (K Units) Figure 25. Asia (Excluding China) Oncology Injection Drug Sales YoY (2021-2032) & (K Units) Figure 26. South America, Middle East and Africa Oncology Injection Drug Sales YoY (2021-2032) & (K Units) Figure 27. Global Oncology Injection Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Oncology Injection Drug Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Oncology Injection Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Oncology Injection Drug Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Oncology Injection Drug Revenue Market Share by Type (2021-2032) Figure 33. Global Oncology Injection Drug Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 34. Global Oncology Injection Drug Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Oncology Injection Drug Sales Market Share by Type (2021-2032) Figure 36. Global Oncology Injection Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Oncology Injection Drug Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Oncology Injection Drug Revenue Market Share by Application (2021-2032) Figure 39. Global Oncology Injection Drug Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 40. Global Oncology Injection Drug Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Oncology Injection Drug Sales Market Share by Application (2021-2032) Figure 42. North America Oncology Injection Drug Revenue Share by Type (2021-2032) Figure 43. North America Oncology Injection Drug Sales Share by Type (2021-2032) Figure 44. North America Oncology Injection Drug Revenue Share by Application (2021-2032) Figure 45. North America Oncology Injection Drug Sales Share by Application (2021-2032) Figure 46. North America Oncology Injection Drug Revenue Share by Country (2021-2032) Figure 47. North America Oncology Injection Drug Sales Share by Country (2021-2032) Figure 48. Europe Oncology Injection Drug Revenue Share by Type (2021-2032) Figure 49. Europe Oncology Injection Drug Sales Share by Type (2021-2032) Figure 50. Europe Oncology Injection Drug Revenue Share by Application (2021-2032) Figure 51. Europe Oncology Injection Drug Sales Share by Application (2021-2032) Figure 52. Europe Oncology Injection Drug Revenue Share by Country (2021-2032) Figure 53. Europe Oncology Injection Drug Sales Share by Country (2021-2032) Figure 54. China Oncology Injection Drug Revenue Share by Type (2021-2032) Figure 55. China Oncology Injection Drug Sales Share by Type (2021-2032) Figure 56. China Oncology Injection Drug Revenue Share by Application (2021-2032) Figure 57. China Oncology Injection Drug Sales Share by Application (2021-2032) Figure 58. Asia Oncology Injection Drug Revenue Share by Type (2021-2032) Figure 59. Asia Oncology Injection Drug Sales Share by Type (2021-2032) Figure 60. Asia Oncology Injection Drug Revenue Share by Application (2021-2032) Figure 61. Asia Oncology Injection Drug Sales Share by Application (2021-2032) Figure 62. Asia Oncology Injection Drug Revenue Share by Country (2021-2032) Figure 63. Asia Oncology Injection Drug Sales Share by Country (2021-2032) Figure 64. SAMEA Oncology Injection Drug Revenue Share by Type (2021-2032) Figure 65. SAMEA Oncology Injection Drug Sales Share by Type (2021-2032) Figure 66. SAMEA Oncology Injection Drug Revenue Share by Application (2021-2032) Figure 67. SAMEA Oncology Injection Drug Sales Share by Application (2021-2032) Figure 68. SAMEA Oncology Injection Drug Revenue Share by Country (2021-2032) Figure 69. SAMEA Oncology Injection Drug Sales Share by Country (2021-2032) Figure 70. Oncology Injection Drug Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Oncology Injection Drug Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Central Nervous System
  • Circulatory/Musculoskeletal System
  • Organs
  • Other
Applications
  • Myeloma
  • Lymphoma
  • Prostate Cancer
  • Other
Companies covered
  • AdvaCare
  • Allos Therapeutics
  • Alza
  • Celgene
  • CordenPharma
  • Debiopharm
  • Ferring Pharmaceuticals
  • Genzyme
  • Merrimack
  • Millennium Pharmaceuticals
  • Pharmascience
  • Praecis Pharmaceuticals
  • S.G. Biopharm
  • Taj Oncology
  • Eli Lilly

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Oncology Injection Drug Market by Type
  3. 1.2.1 Global Oncology Injection Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Central Nervous System
  5. 1.2.3 Circulatory/Musculoskeletal System
  6. 1.2.4 Organs
  7. 1.2.5 Other
  8. 1.3 Oncology Injection Drug Market by Application
  9. 1.3.1 Global Oncology Injection Drug Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Myeloma
  11. 1.3.3 Lymphoma
  12. 1.3.4 Prostate Cancer
  13. 1.3.5 Other
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Oncology Injection Drug Market Dynamics
  1. 2.1 Oncology Injection Drug Industry Trends
  2. 2.2 Oncology Injection Drug Industry Drivers
  3. 2.3 Oncology Injection Drug Industry Opportunities and Challenges
  4. 2.4 Oncology Injection Drug Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Oncology Injection Drug Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Oncology Injection Drug Revenue by Region
  3. 3.2.1 Global Oncology Injection Drug Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Oncology Injection Drug Revenue by Region (2021-2026)
  5. 3.2.3 Global Oncology Injection Drug Revenue by Region (2027-2032)
  6. 3.2.4 Global Oncology Injection Drug Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Oncology Injection Drug Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Oncology Injection Drug Sales by Region
  9. 3.4.1 Global Oncology Injection Drug Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Oncology Injection Drug Sales by Region (2021-2026)
  11. 3.4.3 Global Oncology Injection Drug Sales by Region (2027-2032)
  12. 3.4.4 Global Oncology Injection Drug Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Oncology Injection Drug Revenue by Manufacturers
  2. 4.1.1 Global Oncology Injection Drug Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Oncology Injection Drug Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Oncology Injection Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Oncology Injection Drug Sales by Manufacturers
  6. 4.2.1 Global Oncology Injection Drug Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Oncology Injection Drug Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Oncology Injection Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Oncology Injection Drug Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Oncology Injection Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Oncology Injection Drug Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Oncology Injection Drug Manufacturers, Product Type & Application
  13. 4.7 Global Oncology Injection Drug Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Oncology Injection Drug Market CR5 and HHI
  16. 4.8.2 2025 Oncology Injection Drug Tier 1, Tier 2, and Tier 3
5 Oncology Injection Drug Market by Type
  1. 5.1 Global Oncology Injection Drug Revenue by Type
  2. 5.1.1 Global Oncology Injection Drug Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Oncology Injection Drug Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Oncology Injection Drug Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Oncology Injection Drug Sales by Type
  6. 5.2.1 Global Oncology Injection Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Oncology Injection Drug Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Oncology Injection Drug Sales Market Share by Type (2021-2032)
  9. 5.3 Global Oncology Injection Drug Price by Type
6 Oncology Injection Drug Market by Application
  1. 6.1 Global Oncology Injection Drug Revenue by Application
  2. 6.1.1 Global Oncology Injection Drug Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Oncology Injection Drug Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Oncology Injection Drug Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Oncology Injection Drug Sales by Application
  6. 6.2.1 Global Oncology Injection Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Oncology Injection Drug Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Oncology Injection Drug Sales Market Share by Application (2021-2032)
  9. 6.3 Global Oncology Injection Drug Price by Application
7 Company Profiles
  1. 7.1 AdvaCare
  2. 7.1.1 AdvaCare Company Information
  3. 7.1.2 AdvaCare Business Overview
  4. 7.1.3 AdvaCare Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 AdvaCare Oncology Injection Drug Product Portfolio
  6. 7.1.5 AdvaCare Recent Developments
  7. 7.2 Allos Therapeutics
  8. 7.2.1 Allos Therapeutics Company Information
  9. 7.2.2 Allos Therapeutics Business Overview
  10. 7.2.3 Allos Therapeutics Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Allos Therapeutics Oncology Injection Drug Product Portfolio
  12. 7.2.5 Allos Therapeutics Recent Developments
  13. 7.3 Alza
  14. 7.3.1 Alza Company Information
  15. 7.3.2 Alza Business Overview
  16. 7.3.3 Alza Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Alza Oncology Injection Drug Product Portfolio
  18. 7.3.5 Alza Recent Developments
  19. 7.4 Celgene
  20. 7.4.1 Celgene Company Information
  21. 7.4.2 Celgene Business Overview
  22. 7.4.3 Celgene Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Celgene Oncology Injection Drug Product Portfolio
  24. 7.4.5 Celgene Recent Developments
  25. 7.5 CordenPharma
  26. 7.5.1 CordenPharma Company Information
  27. 7.5.2 CordenPharma Business Overview
  28. 7.5.3 CordenPharma Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 CordenPharma Oncology Injection Drug Product Portfolio
  30. 7.5.5 CordenPharma Recent Developments
  31. 7.6 Debiopharm
  32. 7.6.1 Debiopharm Company Information
  33. 7.6.2 Debiopharm Business Overview
  34. 7.6.3 Debiopharm Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Debiopharm Oncology Injection Drug Product Portfolio
  36. 7.6.5 Debiopharm Recent Developments
  37. 7.7 Ferring Pharmaceuticals
  38. 7.7.1 Ferring Pharmaceuticals Company Information
  39. 7.7.2 Ferring Pharmaceuticals Business Overview
  40. 7.7.3 Ferring Pharmaceuticals Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Ferring Pharmaceuticals Oncology Injection Drug Product Portfolio
  42. 7.7.5 Ferring Pharmaceuticals Recent Developments
  43. 7.8 Genzyme
  44. 7.8.1 Genzyme Company Information
  45. 7.8.2 Genzyme Business Overview
  46. 7.8.3 Genzyme Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Genzyme Oncology Injection Drug Product Portfolio
  48. 7.8.5 Genzyme Recent Developments
  49. 7.9 Merrimack
  50. 7.9.1 Merrimack Company Information
  51. 7.9.2 Merrimack Business Overview
  52. 7.9.3 Merrimack Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Merrimack Oncology Injection Drug Product Portfolio
  54. 7.9.5 Merrimack Recent Developments
  55. 7.10 Millennium Pharmaceuticals
  56. 7.10.1 Millennium Pharmaceuticals Company Information
  57. 7.10.2 Millennium Pharmaceuticals Business Overview
  58. 7.10.3 Millennium Pharmaceuticals Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Millennium Pharmaceuticals Oncology Injection Drug Product Portfolio
  60. 7.10.5 Millennium Pharmaceuticals Recent Developments
  61. 7.11 Pharmascience
  62. 7.11.1 Pharmascience Company Information
  63. 7.11.2 Pharmascience Business Overview
  64. 7.11.3 Pharmascience Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Pharmascience Oncology Injection Drug Product Portfolio
  66. 7.11.5 Pharmascience Recent Developments
  67. 7.12 Praecis Pharmaceuticals
  68. 7.12.1 Praecis Pharmaceuticals Company Information
  69. 7.12.2 Praecis Pharmaceuticals Business Overview
  70. 7.12.3 Praecis Pharmaceuticals Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Praecis Pharmaceuticals Oncology Injection Drug Product Portfolio
  72. 7.12.5 Praecis Pharmaceuticals Recent Developments
  73. 7.13 S.G. Biopharm
  74. 7.13.1 S.G. Biopharm Company Information
  75. 7.13.2 S.G. Biopharm Business Overview
  76. 7.13.3 S.G. Biopharm Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 S.G. Biopharm Oncology Injection Drug Product Portfolio
  78. 7.13.5 S.G. Biopharm Recent Developments
  79. 7.14 Taj Oncology
  80. 7.14.1 Taj Oncology Company Information
  81. 7.14.2 Taj Oncology Business Overview
  82. 7.14.3 Taj Oncology Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Taj Oncology Oncology Injection Drug Product Portfolio
  84. 7.14.5 Taj Oncology Recent Developments
  85. 7.15 Eli Lilly
  86. 7.15.1 Eli Lilly Company Information
  87. 7.15.2 Eli Lilly Business Overview
  88. 7.15.3 Eli Lilly Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Eli Lilly Oncology Injection Drug Product Portfolio
  90. 7.15.5 Eli Lilly Recent Developments
8 North America
  1. 8.1 North America Oncology Injection Drug Market Size by Type
  2. 8.1.1 North America Oncology Injection Drug Revenue by Type (2021-2032)
  3. 8.1.2 North America Oncology Injection Drug Sales by Type (2021-2032)
  4. 8.1.3 North America Oncology Injection Drug Price by Type (2021-2032)
  5. 8.2 North America Oncology Injection Drug Market Size by Application
  6. 8.2.1 North America Oncology Injection Drug Revenue by Application (2021-2032)
  7. 8.2.2 North America Oncology Injection Drug Sales by Application (2021-2032)
  8. 8.2.3 North America Oncology Injection Drug Price by Application (2021-2032)
  9. 8.3 North America Oncology Injection Drug Market Size by Country
  10. 8.3.1 North America Oncology Injection Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Oncology Injection Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Oncology Injection Drug Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Oncology Injection Drug Market Size by Type
  2. 9.1.1 Europe Oncology Injection Drug Revenue by Type (2021-2032)
  3. 9.1.2 Europe Oncology Injection Drug Sales by Type (2021-2032)
  4. 9.1.3 Europe Oncology Injection Drug Price by Type (2021-2032)
  5. 9.2 Europe Oncology Injection Drug Market Size by Application
  6. 9.2.1 Europe Oncology Injection Drug Revenue by Application (2021-2032)
  7. 9.2.2 Europe Oncology Injection Drug Sales by Application (2021-2032)
  8. 9.2.3 Europe Oncology Injection Drug Price by Application (2021-2032)
  9. 9.3 Europe Oncology Injection Drug Market Size by Country
  10. 9.3.1 Europe Oncology Injection Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Oncology Injection Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Oncology Injection Drug Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Oncology Injection Drug Market Size by Type
  2. 10.1.1 China Oncology Injection Drug Revenue by Type (2021-2032)
  3. 10.1.2 China Oncology Injection Drug Sales by Type (2021-2032)
  4. 10.1.3 China Oncology Injection Drug Price by Type (2021-2032)
  5. 10.2 China Oncology Injection Drug Market Size by Application
  6. 10.2.1 China Oncology Injection Drug Revenue by Application (2021-2032)
  7. 10.2.2 China Oncology Injection Drug Sales by Application (2021-2032)
  8. 10.2.3 China Oncology Injection Drug Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Oncology Injection Drug Market Size by Type
  2. 11.1.1 Asia Oncology Injection Drug Revenue by Type (2021-2032)
  3. 11.1.2 Asia Oncology Injection Drug Sales by Type (2021-2032)
  4. 11.1.3 Asia Oncology Injection Drug Price by Type (2021-2032)
  5. 11.2 Asia Oncology Injection Drug Market Size by Application
  6. 11.2.1 Asia Oncology Injection Drug Revenue by Application (2021-2032)
  7. 11.2.2 Asia Oncology Injection Drug Sales by Application (2021-2032)
  8. 11.2.3 Asia Oncology Injection Drug Price by Application (2021-2032)
  9. 11.3 Asia Oncology Injection Drug Market Size by Country
  10. 11.3.1 Asia Oncology Injection Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Oncology Injection Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Oncology Injection Drug Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Oncology Injection Drug Market Size by Type
  2. 12.1.1 SAMEA Oncology Injection Drug Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Oncology Injection Drug Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Oncology Injection Drug Price by Type (2021-2032)
  5. 12.2 SAMEA Oncology Injection Drug Market Size by Application
  6. 12.2.1 SAMEA Oncology Injection Drug Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Oncology Injection Drug Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Oncology Injection Drug Price by Application (2021-2032)
  9. 12.3 SAMEA Oncology Injection Drug Market Size by Country
  10. 12.3.1 SAMEA Oncology Injection Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Oncology Injection Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Oncology Injection Drug Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Oncology Injection Drug Value Chain Analysis
  2. 13.1.1 Oncology Injection Drug Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Oncology Injection Drug Production Mode & Process
  6. 13.2 Oncology Injection Drug Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Oncology Injection Drug Distributors
  9. 13.2.3 Oncology Injection Drug Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst